## Abstract Since the discovery of __perforin__ gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) type 2, heterogeneous features in FHL2 patients have been identified in a report of Feldmann et al. as the beginning. This study was conducted to determine the impact of characteristi
Clinical and molecular aspects of Turkish familial hemophagocytic lymphohistiocytosis patients with perforin mutations
β Scribed by Hamza Okur; Gunay Balta; Nurten Akarsu; Ahmet Oner; Turkan Patiroglu; Ali Bay; Tulin Sayli; Sule Unal; Aytemiz Gurgey
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 94 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Recently, point mutations in the Perforin gene on chromosome 10q21 have been described to be the cause of hemophagocytic lymphohistiocytosis (HLH) in a subset of patients. Small deletions, missense, or nonsense mutations were found in both coding exons of the gene. One mu
## Abstract Recently, mutations of two genes, SAP/SH2D1A/DSHP and perforin genes, have been identified in two fatal inherited lymphoproliferative diseases, Xβlinked lymphoproliferative disease and familial hemophagocytic lymphohistiocytosis, respectively. EpsteinβBarr virus (EBV)βassociated hemopha
Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal-recessive disease that affects young children. It presents as a severe hyperinflammatory syndrome with activated macrophages and T lymphocytes. Mutations in the perforin 1 gene (PRF1) were found in FHL-2 in 15-50% of all cases. Defect